Neutralizing Antibody Market Report: Trends, Forecast and Competitive Analysis to 2030
2 – 3 business days after placing order
Neutralizing Antibody Trends and Forecast
The future of the global neutralizing antibody market looks promising with opportunities in the hospital and clinic, research institute, diagnostic laboratory, and pharmaceutical company markets. The global neutralizing antibody market is expected to grow with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are growing incidence of autoimmune disorders including rheumatoid arthritis, multiple sclerosis, and lupus, rising prevalence of infectious diseases, and increasing awareness of the benefits of antibody-based therapies compared to traditional vaccines and drugs.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Neutralizing Antibody by Segment
The study includes a forecast for the global neutralizing antibody by target virus, antibody type, application, end use, and region.
Neutralizing Antibody Market by Target Virus [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neutralizing antibody companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neutralizing antibody companies profiled in this report include-
Lucintel forecasts that therapeutic will remain the largest segment over the forecast period.
Within this market, pharmaceutical company will remain the largest segment.
North America will remain the largest region over the forecast period due to the existence of important vital firms and a consistent healthcare system across the country.
Features of the Global Neutralizing Antibody Market
Market Size Estimates: Neutralizing antibody market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Neutralizing antibody market size by target virus, antibody type, application, end use, and region in terms of value ($B).
Regional Analysis: Neutralizing antibody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different target virus, antibody type, application, end use, and regions for the neutralizing antibody market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neutralizing antibody market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for neutralizing antibody market?
Answer: The global neutralizing antibody market is expected to grow with a CAGR of 11.2% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the neutralizing antibody market?
Answer: The major drivers for this market are growing incidence of autoimmune disorders including rheumatoid arthritis, multiple sclerosis, and lupus, rising prevalence of infectious diseases, and increasing awareness of the benefits of antibody-based therapies compared to traditional vaccines and drugs.
Q3. What are the major segments for neutralizing antibody market?
Answer: The future of the global neutralizing antibody market looks promising with opportunities in the hospital and clinic, research institute, diagnostic laboratory, and pharmaceutical company markets.
Q4. Who are the key neutralizing antibody market companies?
Answer: Some of the key neutralizing antibody companies are as follows:
Answer: Lucintel forecasts that therapeutic will remain the largest segment over the forecast period.
Q6. In neutralizing antibody market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the existence of important vital firms and a consistent healthcare system across the country.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the neutralizing antibody market by target virus (SARS-CoV-2, HIV, influenza, Ebola, zika, and hepatitis C), antibody type (monoclonal antibodies and polyclonal antibodies), application (therapeutics, diagnostics, research and development, and others), end use (hospitals and clinics, research institutes, diagnostic laboratories, pharmaceutical companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Neutralizing Antibody Market, Neutralizing Antibody Market Size, Neutralizing Antibody Market Growth, Neutralizing Antibody Market Analysis, Neutralizing Antibody Market Report, Neutralizing Antibody Market Share, Neutralizing Antibody Market Trends, Neutralizing Antibody Market Forecast, Neutralizing Antibody Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Neutralizing Antibody Trends and Forecast
The future of the global neutralizing antibody market looks promising with opportunities in the hospital and clinic, research institute, diagnostic laboratory, and pharmaceutical company markets. The global neutralizing antibody market is expected to grow with a CAGR of 11.2% from 2024 to 2030. The major drivers for this market are growing incidence of autoimmune disorders including rheumatoid arthritis, multiple sclerosis, and lupus, rising prevalence of infectious diseases, and increasing awareness of the benefits of antibody-based therapies compared to traditional vaccines and drugs.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Neutralizing Antibody by Segment
The study includes a forecast for the global neutralizing antibody by target virus, antibody type, application, end use, and region.
Neutralizing Antibody Market by Target Virus [Shipment Analysis by Value from 2018 to 2030]:
- SARS-CoV-2
- HIV
- Influenza
- Ebola
- Zika
- Hepatitis C
- Monoclonal Antibodies
- Polyclonal Antibodies
- Therapeutics
- Diagnostics
- Research and Development
- Others
- Hospitals and Clinics
- Research Institutes
- Diagnostic Laboratories
- Pharmaceutical Companies
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neutralizing antibody companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neutralizing antibody companies profiled in this report include-
- Regeneron Pharmaceuticals
- Eli Lilly and Company
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Roche
- Novartis
- Merck
- Pfizer
- Johnson & Johnson
Lucintel forecasts that therapeutic will remain the largest segment over the forecast period.
Within this market, pharmaceutical company will remain the largest segment.
North America will remain the largest region over the forecast period due to the existence of important vital firms and a consistent healthcare system across the country.
Features of the Global Neutralizing Antibody Market
Market Size Estimates: Neutralizing antibody market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Neutralizing antibody market size by target virus, antibody type, application, end use, and region in terms of value ($B).
Regional Analysis: Neutralizing antibody market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different target virus, antibody type, application, end use, and regions for the neutralizing antibody market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neutralizing antibody market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for neutralizing antibody market?
Answer: The global neutralizing antibody market is expected to grow with a CAGR of 11.2% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the neutralizing antibody market?
Answer: The major drivers for this market are growing incidence of autoimmune disorders including rheumatoid arthritis, multiple sclerosis, and lupus, rising prevalence of infectious diseases, and increasing awareness of the benefits of antibody-based therapies compared to traditional vaccines and drugs.
Q3. What are the major segments for neutralizing antibody market?
Answer: The future of the global neutralizing antibody market looks promising with opportunities in the hospital and clinic, research institute, diagnostic laboratory, and pharmaceutical company markets.
Q4. Who are the key neutralizing antibody market companies?
Answer: Some of the key neutralizing antibody companies are as follows:
- Regeneron Pharmaceuticals
- Eli Lilly and Company
- AstraZeneca
- GlaxoSmithKline
- Sanofi
- Roche
- Novartis
- Merck
- Pfizer
- Johnson & Johnson
Answer: Lucintel forecasts that therapeutic will remain the largest segment over the forecast period.
Q6. In neutralizing antibody market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the existence of important vital firms and a consistent healthcare system across the country.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the neutralizing antibody market by target virus (SARS-CoV-2, HIV, influenza, Ebola, zika, and hepatitis C), antibody type (monoclonal antibodies and polyclonal antibodies), application (therapeutics, diagnostics, research and development, and others), end use (hospitals and clinics, research institutes, diagnostic laboratories, pharmaceutical companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Neutralizing Antibody Market, Neutralizing Antibody Market Size, Neutralizing Antibody Market Growth, Neutralizing Antibody Market Analysis, Neutralizing Antibody Market Report, Neutralizing Antibody Market Share, Neutralizing Antibody Market Trends, Neutralizing Antibody Market Forecast, Neutralizing Antibody Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL NEUTRALIZING ANTIBODY MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Neutralizing Antibody Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Neutralizing Antibody Market by Target Virus
3.3.1: SARS-CoV-2
3.3.2: HIV
3.3.3: Influenza
3.3.4: Ebola
3.3.5: Zika
3.3.6: Hepatitis C
3.4: Global Neutralizing Antibody Market by Antibody Type
3.4.1: Monoclonal Antibodies
3.4.2: Polyclonal Antibodies
3.5: Global Neutralizing Antibody Market by Application
3.5.1: Therapeutics
3.5.2: Diagnostics
3.5.3: Research and Development
3.5.4: Others
3.6: Global Neutralizing Antibody Market by End Use
3.6.1: Hospitals and Clinics
3.6.2: Research Institutes
3.6.3: Diagnostic Laboratories
3.6.4: Pharmaceutical Companies
3.6.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Neutralizing Antibody Market by Region
4.2: North American Neutralizing Antibody Market
4.2.1: North American Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
4.2.2: North American Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
4.3: European Neutralizing Antibody Market
4.3.1: European Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
4.3.2: European Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
4.4: APAC Neutralizing Antibody Market
4.4.1: APAC Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
4.4.2: APAC Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
4.5: ROW Neutralizing Antibody Market
4.5.1: ROW Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
4.5.2: ROW Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Neutralizing Antibody Market by Target Virus
6.1.2: Growth Opportunities for the Global Neutralizing Antibody Market by Antibody Type
6.1.3: Growth Opportunities for the Global Neutralizing Antibody Market by Application
6.1.4: Growth Opportunities for the Global Neutralizing Antibody Market by End Use
6.1.5: Growth Opportunities for the Global Neutralizing Antibody Market by Region
6.2: Emerging Trends in the Global Neutralizing Antibody Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Neutralizing Antibody Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neutralizing Antibody Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Regeneron Pharmaceuticals
7.2: Eli Lilly and Company
7.3: AstraZeneca
7.4: GlaxoSmithKline
7.5: Sanofi
7.6: Roche
7.7: Novartis
7.8: Merck
7.9: Pfizer
7.10: Johnson & Johnson
2. GLOBAL NEUTRALIZING ANTIBODY MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Neutralizing Antibody Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Neutralizing Antibody Market by Target Virus
3.3.1: SARS-CoV-2
3.3.2: HIV
3.3.3: Influenza
3.3.4: Ebola
3.3.5: Zika
3.3.6: Hepatitis C
3.4: Global Neutralizing Antibody Market by Antibody Type
3.4.1: Monoclonal Antibodies
3.4.2: Polyclonal Antibodies
3.5: Global Neutralizing Antibody Market by Application
3.5.1: Therapeutics
3.5.2: Diagnostics
3.5.3: Research and Development
3.5.4: Others
3.6: Global Neutralizing Antibody Market by End Use
3.6.1: Hospitals and Clinics
3.6.2: Research Institutes
3.6.3: Diagnostic Laboratories
3.6.4: Pharmaceutical Companies
3.6.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Neutralizing Antibody Market by Region
4.2: North American Neutralizing Antibody Market
4.2.1: North American Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
4.2.2: North American Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
4.3: European Neutralizing Antibody Market
4.3.1: European Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
4.3.2: European Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
4.4: APAC Neutralizing Antibody Market
4.4.1: APAC Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
4.4.2: APAC Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
4.5: ROW Neutralizing Antibody Market
4.5.1: ROW Neutralizing Antibody Market by Application: Therapeutics, Diagnostics, Research and Development, and Others
4.5.2: ROW Neutralizing Antibody Market by End Use: Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, Pharmaceutical Companies, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Neutralizing Antibody Market by Target Virus
6.1.2: Growth Opportunities for the Global Neutralizing Antibody Market by Antibody Type
6.1.3: Growth Opportunities for the Global Neutralizing Antibody Market by Application
6.1.4: Growth Opportunities for the Global Neutralizing Antibody Market by End Use
6.1.5: Growth Opportunities for the Global Neutralizing Antibody Market by Region
6.2: Emerging Trends in the Global Neutralizing Antibody Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Neutralizing Antibody Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neutralizing Antibody Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Regeneron Pharmaceuticals
7.2: Eli Lilly and Company
7.3: AstraZeneca
7.4: GlaxoSmithKline
7.5: Sanofi
7.6: Roche
7.7: Novartis
7.8: Merck
7.9: Pfizer
7.10: Johnson & Johnson
